Benchling and Moderna Expand AI Collaboration in Biotech R&D

Benchling and Moderna have announced an expanded collaboration to integrate AI-driven research across Moderna's R&D operations, announced in a press release. This partnership, initially focused on supporting Moderna's technical development teams, will now extend to the entire research organization, bringing hundreds of scientists onto a unified, AI-ready digital platform.

The collaboration aims to consolidate systems for a seamless experience, automate scientific workflows, and standardize data into AI-ready formats. This digital transformation is designed to enhance productivity and innovation by providing a robust infrastructure for AI applications in biotech research.

Benchling's platform will enable Moderna's teams to design experiments, track samples, and analyze results within a single system, addressing the challenge of integrating diverse data types. This initiative sets a new standard for digital infrastructure in AI-driven R&D, allowing for high-throughput processing of experimental data and reducing setup time for new workflows.